News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
654,167 Results
Type
Article (50006)
Company Profile (223)
Press Release (603913)
Multimedia
Podcasts (184)
Webinars (29)
Section
Business (178279)
Career Advice (2620)
Deals (32858)
Drug Delivery (155)
Drug Development (79713)
Employer Resources (172)
FDA (16730)
Job Trends (13791)
News (316271)
Policy (32822)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2458)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (157)
Alliances (45132)
ALS (194)
Alzheimer's disease (1817)
Antibody-drug conjugate (ADC) (391)
Approvals (16940)
Artificial intelligence (618)
Autoimmune disease (232)
Automation (39)
Bankruptcy (330)
Best Places to Work (10202)
BIOSECURE Act (23)
Biosimilars (215)
Biotechnology (113)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (668)
Cancer (5219)
Cardiovascular disease (456)
Career advice (2214)
Career pathing (44)
CAR-T (285)
CDC (71)
Celiac Disease (1)
Cell therapy (811)
Cervical cancer (39)
Clinical research (68690)
Collaboration (1834)
Company closure (6)
Compensation (1271)
Complete response letters (90)
COVID-19 (2806)
CRISPR (97)
C-suite (953)
Cystic fibrosis (146)
Data (6777)
Decentralized trials (3)
Denatured (51)
Depression (169)
Diabetes (542)
Diagnostics (6062)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (294)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (280)
Earnings (74914)
Editorial (70)
Employer branding (20)
Employer resources (152)
Events (101164)
Executive appointments (1010)
FDA (20123)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (25)
Funding (1491)
Gene editing (213)
Generative AI (55)
Gene therapy (686)
GLP-1 (1160)
Government (4403)
Grass and pollen (8)
Guidances (390)
Healthcare (16146)
HIV (76)
Huntington's disease (57)
IgA nephropathy (93)
Immunology and inflammation (309)
Immuno-oncology (84)
Indications (152)
Infectious disease (3120)
Inflammatory bowel disease (210)
Inflation Reduction Act (15)
Influenza (124)
Intellectual property (263)
Interviews (480)
IPO (15523)
IRA (59)
Job creations (3883)
Job search strategy (1824)
JPM (73)
Kidney cancer (19)
Labor market (94)
Layoffs (635)
Leadership (45)
Legal (7944)
Liver cancer (100)
Longevity (26)
Lung cancer (697)
Lymphoma (396)
Machine learning (48)
Management (59)
Manufacturing (913)
MASH (187)
Medical device (12047)
Medtech (12115)
Mergers & acquisitions (18450)
Metabolic disorders (1508)
mRNA (203)
Multiple sclerosis (178)
NASH (24)
Neurodegenerative disease (396)
Neuropsychiatric disorders (111)
Neuroscience (3253)
Neurotech (2)
NextGen: Class of 2026 (5547)
Non-profit (3478)
Now hiring (63)
Obesity (753)
Opinion (337)
Ovarian cancer (168)
Pain (226)
Pancreatic cancer (249)
Parkinson's disease (352)
Partnered (29)
Patents (545)
Patient recruitment (573)
Peanut (60)
People (54426)
Pharmaceutical (86)
Pharmacy benefit managers (35)
Phase 1 (21205)
Phase 2 (29839)
Phase 3 (23207)
Pipeline (6723)
Policy (364)
Postmarket research (2613)
Preclinical (8631)
Press Release (50)
Prostate cancer (279)
Psychedelics (60)
Radiopharmaceuticals (300)
Rare diseases (1054)
Real estate (5466)
Recruiting (70)
Regulatory (25520)
Reports (47)
Research institute (2308)
Resumes & cover letters (431)
Rett syndrome (32)
RNA editing (19)
RSV (86)
Schizophrenia (169)
Series A (260)
Series B (192)
Service/supplier (14)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (170)
Sponsored (49)
Startups (3395)
State (2)
Stomach cancer (21)
Supply chain (123)
Tariffs (101)
The Weekly (130)
Vaccines (1161)
Venture capital (106)
Weight loss (519)
Women's health (97)
Worklife (23)
Date
Today (3)
Last 7 days (597)
Last 30 days (2656)
Last 365 days (29895)
2026 (7318)
2025 (30203)
2024 (33900)
2023 (37973)
2022 (48623)
2021 (52398)
2020 (49774)
2019 (40610)
2018 (31004)
2017 (31308)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (805)
Alabama (76)
Alaska (7)
Arizona (271)
Arkansas (13)
Asia (40717)
Australia (6737)
California (11720)
Canada (3090)
China (1204)
Colorado (491)
Connecticut (526)
Delaware (360)
Europe (92401)
Florida (1783)
Georgia (356)
Hawaii (4)
Idaho (47)
Illinois (887)
India (77)
Indiana (493)
Iowa (22)
Japan (483)
Kansas (116)
Kentucky (43)
Louisiana (32)
Maine (77)
Maryland (1445)
Massachusetts (8550)
Michigan (289)
Minnesota (623)
Mississippi (5)
Missouri (125)
Montana (21)
Nebraska (26)
Nevada (126)
New Hampshire (68)
New Jersey (3190)
New Mexico (27)
New York (3069)
North Carolina (1539)
North Dakota (7)
Northern California (5837)
Ohio (325)
Oklahoma (19)
Oregon (38)
Pennsylvania (2287)
Puerto Rico (23)
Rhode Island (40)
South America (1179)
South Carolina (70)
South Dakota (1)
Southern California (4597)
Tennessee (178)
Texas (1778)
United States (41358)
Utah (296)
Virginia (292)
Washington D.C. (81)
Washington State (929)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
654,167 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Roche, Zealand’s Amylin Weight Loss Drug Fails To Clear Lilly’s Bar
Zealand Pharma’s shares fell 32% in early morning trading Friday after its Roche-partnered asset petrelintide failed to meet investor expectations in a mid-stage clinical trial.
March 6, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Resolutions from Zealand Pharma’s Annual General Meeting 2026
March 27, 2026
·
4 min read
Press Releases
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
March 24, 2026
·
7 min read
Press Releases
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 9, 2026
·
2 min read
Press Releases
Zealand Pharma convenes its Annual General Meeting 2026
February 19, 2026
·
1 min read
Press Releases
Zealand Pharma Announces Financial Results for the Full Year 2025
February 19, 2026
·
13 min read
Press Releases
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
March 5, 2026
·
11 min read
Press Releases
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
February 18, 2026
·
7 min read
Press Releases
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
February 12, 2026
·
2 min read
1 of 65,417
Next
